There are no files associated with this item.
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.citation.endPage | 2833 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 2809 | - |
dc.citation.title | GEROSCIENCE | - |
dc.citation.volume | 43 | - |
dc.contributor.author | Chae, Jae-Byoung | - |
dc.contributor.author | Jang, Hyoik | - |
dc.contributor.author | Son, Chanok | - |
dc.contributor.author | Park, Chul-Woo | - |
dc.contributor.author | Choi, Huyeon | - |
dc.contributor.author | Jin, Seongeon | - |
dc.contributor.author | Lee, Ho-Yeon | - |
dc.contributor.author | Lee, Hyungwoo | - |
dc.contributor.author | Ryu, Ja-Hyoung | - |
dc.contributor.author | Kim, Namshin | - |
dc.contributor.author | Kim, Chaekyu | - |
dc.contributor.author | Chung, Hyewon | - |
dc.date.accessioned | 2023-12-21T15:06:36Z | - |
dc.date.available | 2023-12-21T15:06:36Z | - |
dc.date.created | 2021-10-22 | - |
dc.date.issued | 2021-12 | - |
dc.description.abstract | Although age-related macular degeneration (AMD) is a multifactorial disorder with angiogenic, immune, and inflammatory components, the most common clinical treatment strategies are antiangiogenic therapies. However, these strategies are only applicable to neovascular AMD, which accounts for less than 20% of all AMD cases, and there are no FDA-approved drugs for the treatment of dry AMD, which accounts for ~ 80% of AMD cases. Here, we report that the elimination of senescent cells is a potential novel therapeutic approach for the treatment of all types of AMD. We identified senescent retinal pigment epithelium (RPE) cells in animal models of AMD and determined their contributions to retinal degeneration. We further confirmed that the clearance of senescent RPE cells with the MDM2-p53 inhibitor Nutlin-3a ameliorated retinal degeneration. These findings provide new insights into the use of senescent cells as a therapeutic target for the treatment of AMD. | - |
dc.identifier.bibliographicCitation | GEROSCIENCE, v.43, no.6, pp.2809 - 2833 | - |
dc.identifier.doi | 10.1007/s11357-021-00457-4 | - |
dc.identifier.issn | 2509-2715 | - |
dc.identifier.scopusid | 2-s2.0-85116264446 | - |
dc.identifier.uri | https://scholarworks.unist.ac.kr/handle/201301/54619 | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs11357-021-00457-4 | - |
dc.identifier.wosid | 000702794400001 | - |
dc.language | 영어 | - |
dc.publisher | SPRINGER | - |
dc.title | Targeting senescent retinal pigment epithelial cells facilitates retinal regeneration in mouse models of age-related macular degeneration | - |
dc.type | Article | - |
dc.description.isOpenAccess | TRUE | - |
dc.relation.journalWebOfScienceCategory | Geriatrics & Gerontology | - |
dc.relation.journalResearchArea | Geriatrics & Gerontology | - |
dc.type.docType | Article; Early Access | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | Aging | - |
dc.subject.keywordAuthor | Age-related macular degeneration | - |
dc.subject.keywordAuthor | Cellular senescence | - |
dc.subject.keywordAuthor | Retina | - |
dc.subject.keywordAuthor | Senolytic | - |
dc.subject.keywordPlus | CELLULAR SENESCENCE | - |
dc.subject.keywordPlus | SECRETORY PHENOTYPE | - |
dc.subject.keywordPlus | GEOGRAPHIC ATROPHY | - |
dc.subject.keywordPlus | CHOROIDAL NEOVASCULARIZATION | - |
dc.subject.keywordPlus | PREMATURE SENESCENCE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | RPE | - |
dc.subject.keywordPlus | INFLAMMASOME | - |
dc.subject.keywordPlus | MEMBRANE | - |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Tel : 052-217-1404 / Email : scholarworks@unist.ac.kr
Copyright (c) 2023 by UNIST LIBRARY. All rights reserved.
ScholarWorks@UNIST was established as an OAK Project for the National Library of Korea.